Search Results

You are looking at 1 - 2 of 2 items for :

  • gonadotropin-releasing hormone x
  • Endocrine Society of Australia special collection x
  • Refine by access: All content x
Clear All
Adam Hagg School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Search for other papers by Adam Hagg in
Google Scholar
PubMed
Close
,
Eliza O’Shea School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Search for other papers by Eliza O’Shea in
Google Scholar
PubMed
Close
,
Craig A Harrison Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Search for other papers by Craig A Harrison in
Google Scholar
PubMed
Close
, and
Kelly L Walton School of Biomedical Sciences, University of Queensland, Brisbane, Australia
Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Search for other papers by Kelly L Walton in
Google Scholar
PubMed
Close

Camus M Tournaye H Fatemi HM Van Steirteghem A & Devroey P 2006 Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles . Fertility and

Free access
Kirsty G Pringle School of Biomedical Sciences & Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia
Mothers and Babies Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia

Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Close
and
Lisa K Philp Australian Prostate Cancer Research Centre - Queensland, Centre for Genomics and Personalised Health & School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, Queensland, Australia

Search for other papers by Lisa K Philp in
Google Scholar
PubMed
Close

human lung cells dampened SARS-CoV-2 cellular entry and subsequent infection, using two drugs that block the androgen axis, bicalutamide, an gonadotropin-releasing hormone agonist, and enzalutamide ( Leach et al. 2021 ). The exact factors driving this

Free access